Product Image

Coenzyme Q10 400 mg

Natural Factors
4.8
★ ★ ★ ★ ★
(825 ratings)
Coenzyme Q-10 400 mg
Product Image
Score93

An ultra-strength 400 mg CoQ10 softgel for intensive mitochondrial and heart support.

How scoring works
Quantity:60 Softgel(s) • (60 servings)
Goals:
Cardiovascular Support
Energy
Heart Health
Anti-Aging
Anti-Inflammatory Support
Metabolism Boost

Score 93

An ultra-strength 400 mg CoQ10 softgel for intensive mitochondrial and heart support.

How scoring works
$48.97($0.81 per serving)
iHerb
$ 48.97
Vitacost
$ 48.97
Report prices

Analysis

Natural Factors offers this 400 mg softgel for individuals with specific, high-level mitochondrial or heart health goals. The softgel uses a lipid base to help the body process such a large amount of ubiquinone.

This is a focused product for people who have been suggested to take higher levels of CoQ10. It is much easier to take one of these than multiple lower-dose pills to reach the same amount.

Pros

  • Very high 400 mg potency
  • Lipid-based for uptake
  • Convenient one-per-day high dose
  • Good for specific therapeutic needs

Cons

  • May exceed basic daily needs
  • Higher cost per serving

Warnings

  • High doses should be used under professional guidance
  • Take with food to minimize digestive side effects

Nutrient quality

89 Highest impact

The 400 mg dose is highly concentrated and well-suited for more intensive cardiovascular goals. While the softgel delivery is optimal for absorption, the ubiquinone form is not as biologically active as ubiquinol.

Ingredient transparency

99 Highest impact

Labeling clearly states the active ingredient amount and providing comprehensive disclosure of softgel components. Transparency is high regarding both serving size and usage guidance.

Customer satisfaction

95 Highest impact

Positive user ratings suggest high satisfaction with the potency and results of the supplement. The volume of reviews provides a reliable perspective on general consumer experience.

Value for money

86 Highest impact

The price per serving reflects the higher potency provided by the 400 mg dose. While more expensive than lower doses, it represents good value for those needing intensive support.

Report analysis

Goals

Impact
Highest effect
A+ Goal FitA Strength of SupportC CoverageA+ Formula Quality

Coenzyme Q10 in a high 400 mg dose provides intensive support for cardiovascular mitochondrial health. Utilizing the ubiquinone form in a lipid-based softgel ensures absorption for this fat-soluble nutrient.

Strong clinical evidence exists for the role of high-dose CoQ10 in supporting cardiac contraction and managing lipid oxidation. This formulation is particularly suited for individuals with elevated needs or those taking medications that deplete these levels.

View goal →
Impact
Highest effect
A Goal FitA- Strength of SupportC CoverageA+ Formula Quality

Ubiquinone is provided in a high-strength 400 mg dose to support mitochondrial function and cardiovascular health. This robust dose is intended for individuals needing significant metabolic support to maintain energy production.

The lipid-based softgel delivery ensures optimal absorption of this fat-soluble component. This high-potency approach appears well aligned with the needs of those seeking maximum mitochondrial support for daily vitality.

View goal →
Impact
Highest effect
A Goal FitA Strength of SupportC CoverageA+ Formula Quality

This ultra-strength formulation provides 400mg of ubiquinone per serving, offering intensive support for cardiac energy and antioxidant defense. High-dose Coenzyme Q10 is particularly relevant for those requiring significant mitochondrial support or those managing specific nutrient depletions.

The softgel format is critical for the delivery of this fat-soluble compound. While ubiquinone is the standard form, this dosage level provides meaningful systemic support for heart muscle function and cardiovascular vitality.

View goal →
Impact
Highest effect
A- Goal FitA Strength of SupportC+ CoverageA+ Formula Quality

Inclusion of an intensive 400 mg dose of ubiquinone provides robust support for mitochondrial health and high-level antioxidant protection. This concentration may contribute to significant improvements in cellular energy status and cardiovascular function under targeted protocols.

Softgel delivery ensures the necessary lipid base for absorption of this potent fat-soluble compound. While highly effective, this elevated dose is often most beneficial for those with specific increased physiological demands or clinically identified needs.

View goal →
Impact
Highest effect
B+ Goal FitA Strength of SupportC CoverageA Formula Quality

An exceptionally high dose of 400 mg ubiquinone provides concentrated support for cardiovascular health and mitochondrial efficiency. This potency level is often utilized in clinical settings to aggressively support antioxidant status and reduce inflammatory signaling.

The lipid-based softgel format is critical for the absorption of such a large dose of this fat-soluble compound. This product offers a focused and highly potent single-ingredient approach for those with intensive goals.

View goal →
Impact
Highest effect
B+ Goal FitA Strength of SupportD+ CoverageA+ Formula Quality

Metabolic support at a cellular level is provided by a high-strength 400 mg dose of ubiquinone. This concentration directly assists the mitochondrial electron transport chain for energy generation.

The lipid-based softgel delivery is essential for maximizing the absorption of the fat-soluble active ingredient. This potency level is particularly useful for those requiring significant support for cellular respiration and metabolic activity.

View goal →

Ingredients

IngredientAmount per serving
Coenzyme Q10 (Ubiquinone)
400 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
B Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value
Natural Factors 400mg CoQ10 delivers a high-strength dose of ubiquinone in an oil-based softgel. It is best suited for those requiring significant cardiovascular support under clinical guidance.
Report alternatives